Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Claret Capital Partners provides €30m financing to Carvolix to accelerate commercialization of its medtech portfolio and transformative technologies.
PRIVATEAug 06, 2026•3 days ago
Amount Raised
€30 Million
Round Type
Venture - Series Unknown
Aix En ProvenceBiotechnologyHealth CareArtificial IntelligenceMedicalMedical Device
Investors
Claret Capital Partners
Description
Claret Capital Partners has invested €30m in Carvolix to support the commercialization of its innovative medical technology. The funding will enhance the development of AI-driven mini-robots for cardiac valve replacement and stroke treatment. Carvolix focuses on expanding access to life-saving procedures like TAVI. The company's lead asset aims to assist cardiologists in executing complex procedures with precision.
Company Information
Company
Carvolix
Location
Aix En Provence, Provence Alpes Côte D'azur, France
About
Carvolix is a commercial and clinical-stage medical technology company specializing in AI-driven mini-robots and biomimetic implants. It aims to revolutionize interventional cardiology and the treatment of brain strokes. The company focuses on addressing major unmet medical needs in large markets. Carvolix was formed through the acquisition of Caranx Medical and Artedrone.